A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS)
Authors:
- Li WangLWLi Wang
- Yao DingYDYao Ding
- Teresa L. BrunoTBTeresa L. Bruno
- R. Jason StaffordRSR. Jason Stafford
- Eric LinELEric Lin
- Tharakeswara K. BathalaTBTharakeswara K. Bathala
- Jeremiah W. SandersJSJeremiah W. Sanders
- Matthew S. NingMNMatthew S. Ning
- Jingfei MaJMJingfei Ma
- Ann H. KloppAKAnn H. Klopp
- Aradhana VenkatesanAVAradhana Venkatesan
- Jihong WangJWJihong Wang
Open Access
Abstract
Magnetic resonance imaging (MRI) can facilitate accurate organ delineation and optimal dose distributions in high-dose-rate (HDR) MRI-Assisted Radiosurgery (MARS). Its use for this purpose has been limited by the lack of positive-contrast MRI markers that can clearly delineate the lumen of the HDR applicator and precisely show the path of the HDR source on T1- and T2-weighted MRI sequences. We investigated a novel MRI positive-contrast HDR brachytherapy or interventional radiotherapy line marker, C4:S, consisting of C4 (visible on T1-weighted images) complexed with saline. Longitudinal relaxation time (T1) and transverse relaxation time (T2) for C4:S were measured on a 1.5 T MRI scanner. High-density polyethylene (HDPE) tubing filled with C4:S as an HDR brachytherapy line marker was tested for visibility on T1- and T2-weighted MRI sequences in a tissue-equivalent female ultrasound training pelvis phantom. Relaxivity measurements indicated that C4:S solution had good T1-weighted contrast (relative to oil [fat] signal intensity) and good T2-weighted contrast (relative to water signal intensity) at both room temperature (relaxivity ratio > 1; r2/r1 = 1.43) and body temperature (relaxivity ratio > 1; r2/r1 = 1.38). These measurements were verified by the positive visualization of the C4:S (C4/saline 50:50) HDPE tube HDR brachytherapy line marker on both T1- and T2-weighted MRI sequences. Orientation did not affect the relaxivity of the C4:S contrast solution. C4:S encapsulated in HDPE tubing can be visualized as a positive line marker on both T1- and T2-weighted MRI sequences. MRI-guided HDR planning may be possible with these novel line markers for HDR MARS for several types of cancer.Keywords
Funding Information
- National Institutes of Health Small Business Innovation Research (1R43CA150320-01A1, P30CA016672)
- Cancer Center Support (CORE) (1R43CA150320-01A1, P30CA016672)
This publication has 80 references indexed in Scilit:
- The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapyBrachytherapy, 2017
- CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapyBrachytherapy, 2013
- Improving prostate brachytherapy quality assurance with MRI–CT fusion–based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancerBrachytherapy, 2013
- Failure modes and effects analysis applied to high-dose-rate brachytherapy treatment planningBrachytherapy, 2013
- American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapyBrachytherapy, 2012
- Differentiation between the effects of T1 and T2* shortening in contrast-enhanced MRI of the breastJournal of Magnetic Resonance Imaging, 1999
- Time and temperature dependence of MR parameters during thermal coagulation of ex vivo rabbit muscleMagnetic Resonance in Medicine, 1998
- 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5TEuropean Radiology, 1997
- Anisotropy of NMR properties of tissuesMagnetic Resonance in Medicine, 1994
- Temperature dependence of proton relaxation times in vitroMagnetic Resonance Imaging, 1987